EcoDrugPlus

Natriuretic Peptide Receptor 1

Ensembl ID : ENSCVAG00000004931
Gene Symbol: NPR1
3 Cross references
194 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSCVAG00000010289
Gene Symbol: NPR2
2 Cross references
186 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSCVAG00000021567
Gene Symbol: NPR3
3 Cross references
210 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 1-Like

Ensembl ID : ENSCVAG00000021508
Gene Symbol: LOC107098104
3 Cross references
200 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 2-Like

Ensembl ID : ENSCVAG00000012928
Gene Symbol: LOC107083079
3 Cross references
194 Possible Orthologues:

Neuromedin-K Receptor-Like

Ensembl ID : ENSCVAG00000003176
Gene Symbol: LOC107091130
3 Cross references
201 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-2-Like

Ensembl ID : ENSCVAG00000007248
Gene Symbol: LOC107088333
3 Cross references
195 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSCVAG00000012850
Gene Symbol: NPY2R
3 Cross references
183 Possible Orthologues:

Neuropeptide Y Receptor Type 2-Like

Ensembl ID : ENSCVAG00000021032
Gene Symbol: LOC107082272
3 Cross references
176 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSCVAG00000015541
Gene Symbol: NTSR1
1 Cross references
198 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSCVAG00000020716
Gene Symbol: NTRK1
3 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSCVAG00000006368
Gene Symbol: NTRK2
3 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).